At a glance
ClinicalIndex Comparison RecordN/ACompleted· 82 enrolled
Drug / intervention
TRP-200 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Visual Performance of Senofilcon A With and Without a New UV/HEV-filter
In Brief
A clinical study evaluating TRP-200 and ACUVUE Oasys 1-Day for Visual Performance. Completed, enrolled 82 participants across 1 site.
Detailed Summary
This study will occur in two non-dispensing phases: Phase 1 is a non-randomized, non-masked, non-dispensing study where subjects will wear their own contact lenses for approximately 1 hour. Phase 2 is a controlled, randomized, double-masked, contralateral non-dispensing study where the study lenses will be worn in a daily wear modality for approximately 3 hours.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Performance
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartAug 2021
First PostedAug 2021
Primary CompletionOct 2021
TodayJul 2026
First PostedAug 25, 2021
Enrollment StartAug 23, 2021
Primary CompletionOct 20, 2021
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 4.9 years ago
Interventions
TRP-200device
JJVC Investigational Contact Lens
ACUVUE Oasys 1-Daydevice
JJVC Marketed Contact Lens